Pridgen William 4
4 · Virios Therapeutics, Inc. · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Pridgen William
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-28$7.80/sh+801$6,248→ 727,993 total - Purchase
Common Stock
[F1]2021-01-29$7.47/sh+3,500$26,145→ 3,500 total(indirect: By 401(k)) - Exercise/Conversion
Warrant to Purchase Common Stock
[F2]2021-01-28−801→ 0 totalExercise: $7.80From: 2020-12-16Exp: 2021-01-20→ Common Stock (801 underlying)
Footnotes (2)
- [F1]The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.
- [F2]The Reporting Person provided notice of exercise to the Issuer on January 20, 2021 and the Company authorized the issuance of the shares pursuant to such exercise on January 28, 2020.
Signature
/s/ Greg Duncan, Attorney-in-Fact for William Pridgen|2021-02-01